{"title": "NovaDigm Therapeutics Raises $14M Series B to Support Phase 2 Trial of NDV-3 Vaccine Against Candida NovaDigm Therapeutics", "author": "Emily Mullin", "url": "https://www.fiercebiotech.com/biotech/novadigm-therapeutics-raises-14m-series-b-to-support-phase-2-trial-of-ndv-3-vaccine-0", "hostname": "fiercebiotech.com", "description": "NovaDigm Therapeutics a company developing innovative vaccines for fungal and bacterial infections today announced that it has closed a $14M Series B financing. Participating investors included new... | NovaDigm Therapeutics a company developing innovative vaccines for fungal and bacterial infections today announced that it has closed a $14M Series B financing. Participating investors included new...", "sitename": "FierceBiotech", "date": "2013-10-03", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}